A new diagnostic test being developed by a Kiwi biochemist could help save the lives of pregnant women and their babies.
Pre-eclampsia is a life-threatening condition for both mother and child that occurs in around five per cent of pregnancies, and often requires early delivery of the baby.
Dr Jennifer Crowther, a post-doctoral researcher at the University of Canterbury, said it remained one of the leading causes of maternal and foetal disease and death worldwide.
Being able to predict the risk for pre-eclamptic complications earlier could help doctors intervene with specialised care, close monitoring and targeted interventions.
A key indication of pre-eclampsia was higher levels of a specific protein in the mother's blood.